Abstract
The Aedes aegypti mosquito is a vector of dengue, Zika, and chikungunya. The mosquito’s reliance on blood facilitates the transmission of these viral pathogens to humans. Digestion of blood proteins depends on the biphasic expression of serine proteases, with trypsin-like activity contributing to most of the activity in the midgut. Other proteases found (serine collagenase- and chymotrypsin-like) are thought to contribute to digestion, but their roles are largely understudied. Thus, elucidating the activity and specific roles of all midgut proteases will help understand the complexity of the digestion process and help validate them as potential targets for the development of a new vector control strategy. Herein, we focused on characterizing the activity profile and role of Ae. aegypti chymotrypsin (AaCHYMO). Knockdown studies resulted in elimination and significant reduction of chymotrypsin-like activity in blood fed midgut extracts, while in vitro fluorescent and blood protein digestion assays revealed important substrate specificity differences. Interestingly, knockdown of AaCHYMO did not impact fecundity, indicating the presence of an intricate network of proteases working collectively to degrade blood proteins. Further, knockdown of the ecdysone receptor (EcR) led to a decrease in overall AaCHYMO expression and activity in the mosquito, which may play an important regulatory role.
Similar content being viewed by others
Introduction
The Aedes aegypti mosquito relies on the digestion of blood meal proteins by midgut proteases to successfully complete the gonotrophic cycle and lay eggs. Two major classes of proteolytic enzymes responsible for this activity are serine-like endopeptidases (mainly trypsin-, chymotrypsin-, and serine collagenase-like) and exopeptidases that are released into the midgut lumen after imbibing a blood meal1,2,3. Blood meal digestion is biphasic with trypsin-like activity responsible for most, if not all, proteolytic activity found in both the early phase (beginning immediately after a blood meal) and the late phase (beginning around 12 to 18 h post-blood meal (PBM))1,2,3. Because of this, Ae. aegypti midgut blood meal digestion studies have mainly focused on trypsin-like proteases1,3,4,5, with the contribution of chymotrypsin-like proteases being minimal or relatively unknown. Since 1997, only three chymotrypsin-like proteases have been described in the literature. The first of these enzymes, AaCHYMO, led to an increase in protein expression and activity in mosquito midgut extracts, only after a blood meal, suggesting a role in digestion6. The second chymotrypsin-like protease (Juvenile Hormone Associated 15, JHA15) was identified in 2008, and initial studies showed that the knockdown of the protease leads to no phenotypic changes in the mosquito despite being present in the midgut during the early phase portion of blood meal digestion7. The third chymotrypsin-like protease (chymotrypsin II, AaCHYMO II) was identified in 2023, and was shown to be present in both larvae and adult female mosquitoes, but its role in blood meal digestion was not explored8.
Due to the Ae. aegypti mosquito reliance on blood to fuel the gonotrophic cycle, elucidating the activity of all midgut proteases will help better understand the complexity of the blood meal digestion process. In doing so, we can validate these proteolytic enzymes as potential inhibitor targets1,3,4,5. The Aedes mosquito species’ (Ae. aegypti and Ae. albopictus) reliance on blood has facilitated the spread of arthropod-borne viruses (i.e., arboviruses), such as dengue (DENV), Zika (ZIKV), and chikungunya (CHIKV) to uninfected human hosts9. The prevalence of ZIKV has been on the rise since 2007, with a major outbreak in the United States in 2015, which was denoted by severe clinical manifestations (organ failure), birth defects (microcephaly), fetal death, and Guillain-Barré syndrome10. Although ZIKV, DENV, and CHIKV are more prevalent in tropical settings, due to the ever-changing climate, Ae. aegypti and Ae. albopictus have been present in Florida and Texas11,12. In addition, low-level locally acquired DENV and CHIKV infections have been reported and ongoing in these regions, and may become more susceptible to viral transmission, leading to a permanent establishment of locally acquired infections11,12.
Fortunately, insecticides remain the only successful vector control strategy, but even then, the heavy use of commercially available pesticides has led to resistance in Ae. aegypti mosquitoes13,14. Biological methods, such as the use of sterile- or Wolbachia-infected mosquitoes, have shown promise in suppressing the mosquito population and viral replication, but logistical issues in production and release of these mosquitoes have limited their use13,15,16. Given these limitations, targeting blood meal protein digestion may be an alternative approach to mosquito population control. After imbibing a blood meal, midgut proteases are expressed and released into the midgut lumen which then process blood proteins into the necessary nutrients used by the mosquito. In certain cases, when midgut protease expression is knocked down (as is the case with Ae. aegypti Serine Protease VI (AaSPVI), AaSPVII, and Late Trypsin (AaLT)) fecundity is affected leading to ~ 22.9% overall reduction in egg production1. However, the targeting of midgut proteases may be challenging given the complex network of other endo- and exopeptidases that are released1,2,3,17.
Recently, we determined the global proteolytic profile of Ae. aegypti midgut tissue extracts from sugar and blood fed mosquitoes using Multiplex Substrate Profiling by Mass Spectrometry (MSP-MS), revealing the synergistic importance of proteolytic activity on the digestion of blood meal proteins3. Surprisingly, AaCHYMO alone cleaved 22% (32/146) of the peptide bonds in the peptide library suggesting a potentially important role in blood meal protein digestion. Additionally, MSP-MS was utilized to determine the substrate preference at the P1 cleavage site for AaCHYMO, confirming the protease to be chymotrypsin-like3. However, the goal of the MSP-MS study was to better understand the complexity of blood meal digestion by comparing the specificity profiles between midgut extracts post-blood feeding and purified recombinant midgut proteases. The study did not fully characterize or elucidate the role of each individual midgut proteases, including AaCHYMO3. Thus, in the present study we focused on determining the activity profile and role of AaCHYMO in blood protein digestion and ascertain its significance in the Ae. aegypti mosquito gonotrophic cycle. Knockdown of AaCHYMO in the mosquito led to elimination and significant reduction in chymotrypsin-like activity in midgut extracts. In addition, the knockdown of the ecdysone receptor (EcR), a key nuclear receptor that plays an important role in the mosquito gonotrophic cycle18, led to an effect on AaCHYMO expression and chymotrypsin-like activity in mosquito midgut extracts. Further, recombinant AaCHYMO was expressed, purified, and activated for in vitro fluorescent and blood protein digestion activity assays, and compared to human and bovine chymotrypsin. Results reveal important substrate specificity differences, especially in the degradation of human blood meal proteins. Taken together, understanding the role of AaCHYMO and other understudied midgut proteases will aid in validating these enzymes as potential targets for the development of inhibitors and a new vector control strategy.
Results
Proteolytic activity assays indicate specific substrate preferences between mosquito AaCHYMO, human and bovine chymotrypsin
Active recombinant AaCHYMO activity was tested against several commercially available chymotrypsin substrates (Supplementary Table S1) and fit to the Michaelis-Menten (MM) equation (a gel of purified AaCHYMO and representative MM plots are shown in Supplementary Figure S1). Out of the 14 chymotrypsin substrates tested, MeO-Suc-Arg-Pro-Tyr-AMC resulted in the best kinetic parameters with kcat = 14.2 s− 1, Km = 9.52 µM, and kcat/Km = 1,481,520 M− 1 s− 1 (Table 1). For comparison, commercially available human and bovine chymotrypsin were also tested and found to have higher overall kinetic parameters than AaCHYMO for this substrate and the other commercially available chymotrypsin substrates. In some cases, kcat/Km values for human and bovine chymotrypsin were more than 26- and 6000-fold higher than AaCHYMO, respectively (Table 1). The worst commercially available substrate processed by AaCHYMO (Suc-Leu-Leu-Val-Tyr-AMC, kcat = 0.063 s− 1, Km = 6.72 µM, kcat/Km = 9,410 M− 1 s− 1) was the overall most processed by both human (kcat = 597 s− 1, Km = 6.65 µM, kcat/Km = 89,814,954 M− 1 s− 1) and bovine chymotrypsin (kcat = 580.3 s− 1, Km = 10.67 µM, kcat/Km = 54,389,253 M− 1 s− 1). Interestingly, human chymotrypsin did not readily process chymotrypsin substrates with a Leu at the P1 site, while AaCHYMO and bovine chymotrypsin did, with AaCHYMO having an overall higher specificity constant (kcat/Km) when Leu is at the P1 site (Table 1). In addition, two trypsin-like substrates (Boc-Val-Leu-Lys-AMC and Z-Arg-Arg-AMC) were tested, and only human chymotrypsin readily processed these substrates.
Given the differences in chymotrypsin-like activity observed, we ordered AaCHYMO-specific fluorescent AMC substrates with preferred amino acids at the P1 and P2-P4 sites, based on previously characterized proteolytic profiles of AaCHYMO3. Using these specifically designed substrates, we determined AaCHYMO kinetic parameters and compared them to human and bovine chymotrypsin (Table 1). Amino acid residues at the P1 position influenced the activity of AaCHYMO resulting in the protease better processing of AaCHYMO-specific AMC substrates. For example, when Phe and Met are at the P1 site, AaCHYMO had an overall better specificity constant (kcat/Km) than human and bovine chymotrypsin. Conversely, AaCHYMO was not as efficient as the mammalian chymotrypsin proteases when Trp or Tyr are at P1 (Table 1). The only exception where AaCHYMO had no detectable activity from one of the AaCHYMO designed substrates was with Ac-Ala-His-Asp-Trp-AMC. In this case, the substrate was designed with a non-preferred amino acid at the P2 position (aspartate)3 to determine the importance of amino acids beyond the P1 site. Human and bovine chymotrypsin readily cleaved the substrate, having kcat/Km values greater than 3 × 106 M− 1 s− 1.
Western blot analysis of AaCHYMO expression, and proteolytic assays reveal activity in previously undetected mosquito extracts and tissues
We aimed to detect if AaCHYMO would be present in blood fed midgut extracts (with and without the food bolus) and at different life stages. First, AaCHYMO was detected in midgut extracts prepared without the food bolus (midgut epithelial cells only) (Fig. 1A). In sugar-fed (SF) samples, AaCHYMO is clearly present, followed by detection in the 3 to 24 h PBF samples, absent at 36 and 48 h, and relative protease expression observed once again at 72 h PBF. Using the midgut epithelial cell samples only, relative AaCHYMO protein levels were quantified using ImageJ (Fig. 1B). For comparison, midgut extracts with both the midgut epithelial cells and food bolus were analyzed (Fig. 1C). In these samples, AaCHYMO is detected at all the time points tested, with minimal detection in SF and at 72 h PBF. Due to the presence of AaCHYMO in the epithelial cells and food bolus, these samples were used to confirm the presence of chymotrypsin-like activity in mosquito midgut tissue extracts. Activity was confirmed using the optimal commercially available chymotrypsin substrate (MeO-Suc-Arg-Pro-Tyr-AMC, see Supplementary Figure S1B and Table 1). Interestingly, no detectable chymotrypsin-like activity is observed in sugar-fed and 72 h PBF midgut extract samples, indicating that the species present is the zymogen form of AaCHYMO (Fig. 1D). An increase in chymotrypsin-like activity observed at 12, 24, and 36 h PBF correlates with active AaCHYMO, with minimal activity observed at 48 h PBF. Second, to confirm that AaCHYMO-like activity is only found in the midgut of the female mosquito, different tissues were also processed and tested. The pupae, male adult mosquitoes, female carcasses (without the midgut), and the midgut without the food bolus were found to have minimal detection of chymotrypsin-like activity when compared to the larvae and the food bolus (Fig. 1E), as well as the midgut extracts at the different timepoints PBF (Fig. 1C). This indicates that AaCHYMO is localized to the midgut and activated only after a blood meal is ingested.
Western blot (WB) analysis and chymotrypsin-like activity detection in different Ae. aegypti mosquito tissues. (A) Representative fluorescent WB of sugar (SF) and blood fed midgut epithelial cell samples without the food bolus detecting the presence of AaCHYMO at the time points indicated post blood feeding (PBF). α-tubulin was used as an internal control. The blot was cropped to separate out each independent set of samples. (B) Relative AaCHYMO protein levels detected in SF and blood fed mosquito midgut epithelial cell samples. The relative protein levels with standard error of the mean were quantified from the blot in (A) using ImageJ software. Experiments were conducted from 3 biological cohorts using 5 to 10 mosquitoes. One-way ANOVA with Tukey multiple comparisons were employed. The letters above the columns demonstrate statistically significant differences between the groups. (C) Representative chemiluminescent WB of sugar- and blood-fed midgut extracts that contain the midgut epithelial cells plus the food bolus (0.5 midgut equivalents were used for analysis). The WB was cropped to separate out each independent set of samples and to allow the addition of the MW ladder. (D) Chymotrypsin-like activity detected in midgut extracts in the presence of the food bolus using the MeO-Suc-Arg-Pro-Tyr-AMC substrate, which corresponds to the presence of active AaCHYMO. Midgut samples were dissected from sugar-fed only, and 3 to 48 h PBF mosquitoes. Data are presented as mean ± SEM. One-way ANOVA with Tukey multiple comparisons were employed. The letters above the columns demonstrate statistically significant differences between the groups. (E) Detection of minimal chymotrypsin-like activity in pupae, adult male mosquitoes, female carcasses (without the midgut), and midgut tissues without the food bolus (-FB). Higher chymotrypsin-like activity was detected in larvae and the food bolus when compared to the other tissues. Experiments were conducted from 4 biological cohorts, each with 3 sets of samples. One-way ANOVA with Tukey multiple comparisons were employed. The letters above the columns demonstrate statistically significant differences between the groups. Please note that the original blots for (A and C) (each with two independent sets) are presented in Supplementary File 1.
Knockdown studies of AaCHYMO led to the detection of residual chymotrypsin-like activity and no effect on fecundity
We proceeded to determine the overall activity contribution of AaCHYMO in the mosquito midgut. After knockdown of the gene, AaCHYMO mRNA and protein expression were eliminated at 3 h and 18 h PBF (Fig. 2A and D). When comparing FLUC vs. AaCHYMO knocked down midgut tissue extracts, complete elimination of chymotrypsin-like activity is observed from 3 h to 24 h PBF, and a significant reduction in overall activity is observed at 36 h PBF (****p < 0.0001) and 48 h PBF (**p < 0.05) (Fig. 2E). Since chymotrypsin-like activity was not eliminated at 36 h and 48 h PBF, we decided to perform a double knockdown of AaCHYMO and the late phase protease, AaLT (Fig. 3). Recent MSP-MS profiling of AaLT revealed that the protease is not a trypsin but rather has more chymotrypsin- and serine collagenase-like specificity3. This would help identify if the remaining activity is coming from AaLT or a different protease. Although both proteases were knocked down, verified via WB (Fig. 3A and C), and both protein (Fig. 3B and D) and mRNA (Fig. 3E-G) expression levels quantified, there were no significant changes in chymotrypsin-like activity using the MeO-Suc-Arg-Pro-Tyr-AMC substrate at the 36 h and 48 h PBF timepoints (Fig. 3I) indicating that another chymotrypsin-like protease may be responsible for the residual activity observed.
RNAi knockdown efficiency and chymotrypsin-like activity determination in individual Ae. aegypti mosquito midgut tissue extracts. Representative western blot (WB) of mosquito midgut extracts at 3 h PBM (A) and 18 h PBM (B). α-tubulin was used as an internal control. The WBs in (A and B) were cropped for clarity. The original blots are presented in Supplementary File 1. Quantification of AaCHYMO protein expression (C) and quantification of mRNA levels via qPCR (D). Data was obtained from individual midgut of 12 mosquitoes. Data are presented as mean ± SEM. Statistical significance is represented by stars above each comparison (unpaired Student’s t-test; **** p < 0.0001 compared to the RNAi-FLUC control samples). Detection of chymotrypsin-like activity in FLUC vs. RNAi AaCHYMO mosquito midgut extracts using the MeO-Suc-Arg-Pro-Tyr-AMC substrate (E). Activity is eliminated in the 3 h to 24 h PBF samples, with an overall significant reduction in chymotrypsin-like activity at 36 h PBM (****p < 0.0001) and at 48 h PBM (**p < 0.05).
Double RNAi knockdown of AaCHYMO and AaLT in individual Ae. aegypti mosquitoes. (A) Western blot (WB) analysis showing that the double knockdown led to an effect on AaCHYMO expression (seven individual mosquitoes) and compared to the FLUC control (two individual mosquitoes). α-tubulin was used as an internal control. The WBs were cropped for clarity. (B) Quantification of AaCHYMO protein expression levels in midgut extracts with the RNAi double knockdown of AaCHYMO and AaLT compared to FLUC. (C) Western blot analysis showing that knockdown of AaLT has no effect on AaCHYMO expression. α-tubulin was used as an internal control. The WBs were cropped for clarity. (D) Quantification of AaCHYMO protein expression levels in midgut extracts with the RNAi knockdown of AaLT compared to FLUC. E. Quantification of AaCHYMO mRNA levels in mosquito midgut tissues with the RNAi double knockdown of AaCHYMO and AaLT compared to FLUC. (F) Quantification of AaLT mRNA levels in mosquito midgut tissues with the RNAi double knockdown of AaCHYMO and AaLT compared to FLUC. (G) Quantification of AaLT mRNA levels in mosquito midgut tissues with the RNAi knockdown of AaLT compared to FLUC. (H) Quantification of AaCHYMO mRNA levels in mosquito midgut tissues with the RNAi knockdown of AaLT compared to FLUC. Experiments in (B, D, and E-H) were conducted from 3 biological cohorts using 5 to 12 mosquitoes. Data are presented as mean ± SEM. Statistical significance is represented by stars above each comparison (unpaired Student’s t-test; **** p < 0.0001 compared to the RNAi-FLUC control samples, ns = no significance). (I) Activity assays comparing the RNAi AaCHYMO alone knockdown versus the AaCHYMO/AaLT double knockdown using the MeO-Suc-Arg-Pro-Tyr-AMC substrate. No significant changes in overall activity were observed in the double knockdown (4 to 7 biological cohorts using 3 mosquitoes were tested). Please note that the original blots for (A and C) are presented in Supplementary File 1.
Given the possibility that individual knockdown of midgut proteases can lead to a direct effect on fecundity1, maximal egg production in individual RNAi AaCHYMO mosquitoes was measured. The absence of AaCHYMO did not affect egg production (Supplementary Figure S2).
Human blood protein digestion assays reveal AaCHYMO cannot process globular proteins
Further characterizing the role of AaCHYMO in blood meal protein digestion, we co-incubated the enzyme with HSA, Hb, and IgG. These blood proteins are known to be processed into polypeptides and amino acids used by the mosquito1. To detect potential cleavage products by AaCHYMO a 10:1 (protein to protease) ratio was set and compared to the activity of human and bovine chymotrypsin. Interestingly, AaCHYMO did not readily cleave all three blood meal proteins like human and bovine chymotrypsin (Fig. 4). For instance, in the HSA reactions, AaCHYMO digestion led to only a single cleavage product running near 30 kDa (teal arrow in Fig. 4A) and no notable decrease in overall intact HSA. Conversely, multiple cleavage products were observed for human and bovine chymotrypsin, as well as a visible decrease in the amount of intact HSA. Similarly, a single cleavage product by AaCHYMO was observed near 30 kDa (red arrow in Fig. 4B) without digesting any more Hb. Human and bovine chymotrypsin cleaved Hb leading to several cleavage products observed below 15 kDa (Fig. 4B). The mammalian chymotrypsin enzymes also cleaved the Hb species above 30 kDa (blue arrow in Fig. 4B). Lastly, in the IgG reactions (Fig. 4C), various cleavage products were observed for human and bovine chymotrypsin, but only one single cleavage product observed at 15 kDa for AaCHYMO (aqua arrow in Fig. 4C). Two additional cleavage products were observed between 50 and 70 kDa in all three reactions (red and orange arrows in Fig. 4C as a representative example), which were readily digested by human and bovine chymotrypsin.
Protein gel electrophoresis analysis of AaCHYMO, human and bovine chymotrypsin digestion assays with the three major human blood proteins: human serum albumin (HSA) (A), hemoglobin (Hb) (B), and immunoglobulin G (IgG) (C), incubated for a total of 60 min post-protease addition. Time = 0 min is the no protease control in each reaction. (A) Comparing the HSA digestion fragments of AaCHYMO only one single cleavage product is observed (teal arrow), as opposed to several digestion fragments observed in human and bovine chymotrypsin digestion assays. (B) In the Hb digestion assays, only one single cleavage product is observed (red arrow), while the higher molecular weight (MW) Hb band protein species (blue arrows) stays intact throughout the whole reaction time but is readily degraded by human and bovine chymotrypsin. (C) In the IgG digestion assays, the two top bands in between the 50 and 70 kDa MW marker (red and orange arrows) remain intact throughout the reaction time, with only a single cleavage product observed appearing at 20 min after protease addition (aqua arrow). Human and bovine chymotrypsin readily degrade the two bands between the 50 and 70 kDa MW marker (red and orange arrows in the AaCHYMO digestion reaction), with more observable cleavage products below the 30 kDa MW marker observed. The protein gels shown in the figure were cropped for clarity. The original unaltered protein gels are presented in Supplementary File 1.
With these surprising digestion results, we decided to analyze the midgut protein content in the RNAi AaCHYMO- and FLUC-injected mosquito midgut tissue extracts used for the detection of proteolytic activity (Figs. 1 and 2). Analyzing this content should reveal differences in the digestion of blood proteins if AaCHYMO is absent. Only three selected protein species found in all gel samples were analyzed and are shown in representative gels for both FLUC and RNAi AaCHYMO (see purple, red, and teal arrows in Fig. 5A). Overall, there are no significant differences in the digestion of the three proteins (Fig. 5B-D). In fact, all gels (FLUC vs. RNAi AaCHYMO) did not display notable differences, except for the 3 h timepoint of RNAi AaCHYMO vs. FLUC (p value < 0.05) with protein products found between 50 and 70 kDa (red arrow in Fig. 5A and data in Fig. 5C), where the band in the RNAi AaCHYMO is visibly lighter than the other timepoints.
Ae. aegypti midgut blood protein digestion extract analysis. (A) Representative protein gels of FLUC and RNAi AaCHYMO midgut extracts collected at 3 h to 72 h PBF (0.006 midgut equivalents were loaded onto a NuPAGE 4–12% BIS-TRIS gel (Invitrogen)). The protein gels shown in the figure were cropped for clarity and combined for direct comparison. The original unaltered protein gels are presented in Supplementary File 1. MW represents the pre-stained PageRuler protein ladder in kilodaltons (kDa) (Thermo Scientific #26616). (B) Column plot comparing the pixel area of the protein species running at the 70 kDa MW marker (purple arrow in A) between RNAi AaCHYMO and FLUC midgut extract samples. (C) Column plot comparing the pixel area of the protein species running between the 50 and 70 kDa MW marker (red arrow in A) between RNAi AaCHYMO and FLUC midgut extract samples. D. Column plot comparing the pixel area of the protein species running at the 15 kDa MW marker (teal arrow in A) between RNAi AaCHYMO and FLUC midgut extract samples.
Human blood protein digestion specificity is supported by molecular docking simulations
Aiming to predict the potential interactions of AaCHYMO with the three suggested substrates (HSA, Hb, and IgG), we employed a consensus with three different docking software. First, docking simulations using HDOCK predicted a few potential interactions for HSA with AaCHYMO (Fig. 6A), which were not within feasible distances for possible interactions (~ 5 Å)19,20 close to the catalytic site. A docking score of -193.74 and a confidence score of 0.70 were predicted, which could suggest HSA is likely to interact, as protein-protein complexes in the PDB have a docking score of around − 200 and are likely to interact when having a confidence score above 0.7 21. Similarly, Hb was predicted likely to interact, having a score of -208.6 and confidence of 0.76, but no feasible interactions were observed close to the catalytic serine (Fig. 6B). These results suggest that the two human proteins can potentially engage, but inconclusive for full cleavage to occur. Conversely, IgG is predicted to likely interact (-252.11 and 0.88) with AaCHYMO (Fig. 6C), especially at the edge of both its light (-284.26 and 0.93) and heavy chains (-319.24 and 0.96) and being closer to the catalytic site (~ 7 Å, ranging from 5.3 to 9 Å). Also, additional interactions are predicted around the catalytic site, which could support the stabilization of these contacts.
AaCHYMO is predicted to interact with IgG and less likely to interact with human albumin or hemoglobin. Modeled structure of AaCHYMO by AlphaFold2 (gray) was submitted to HDOCK to predict potential interactions with (A) human serum albumin (PDB ID: 1E7H, slate blue), (B) human hemoglobin (PDB ID: 1GZX, salmon), and (C) human neutralizing IgG (PDB ID: 1HZH, cyan). Predictions suggest the latter’s potential to interact and have residues close to the catalytic site of the enzyme (~ 7Å). Results suggest that the two other human proteins can potentially engage, but inconclusive for full cleavage to occur. Predicted interactions are shown as black dashed lines, while measured distances to the catalytic serine are shown as yellow dashed lines. Heme groups are displayed as sticks (brown). Catalytic residues are displayed as sticks (gray) and labeled (H48, D97, and S193). Structures are represented by cartoons and a transparent surface. All images were generated with PyMOL software (v2.5.7).
Consistently, simulations using HADDOCK 2.4 were able to find 15 potential structures for IgG interactions with AaCHYMO, grouped in seven different clusters suggesting their potential PPI, while only four potential structures in two clusters were found for both HSA and Hb. Notable score differences between each cluster, which are supportive of PPI22, were observed for IgG (ranging from − 55.2 ± 7.2 to -16.4 ± 0.7) and albumin (-42.1 ± 8.8 and − 28.7 ± 5.9), but not for hemoglobin (-57.7 ± 2.3 and − 50.2 ± 5.5). Lastly, the three proteins are not predicted to interact with AaCHYMO by PEPPI simulations. Herein, HSA, Hb, and IgG structures were predicted to have negative likelihood ratios (LR < 0) of -2.412, -2.331, and − 2.045, respectively, which usually classify two proteins as non-interacting23. Interestingly, however, IgG had the highest difference (9.192 vs. 1.554) between the positive prediction score (structure similarity, i.e., SPRING) vs. the negative prediction score (non-interaction similarity, i.e., SPRINGNEG)23. This could suggest a higher potential of IgG to interact with AaCHYMO when compared to albumin (3.673 vs. 2.212) and hemoglobin (4.782 vs. 3.376). Overall, these docking simulations for PPI support our digestion assays (Fig. 4).
Knockdown of EcR reveals possible regulation of AaCHYMO expression and activity
To explore the potential role of EcR in AaCHYMO protease regulation, knockdown studies were conducted and chymotrypsin-like activity detected using the MeO-Suc-Arg-Pro-Tyr-AMC substrate. The knockdown of EcR led to an overall decrease in AaCHYMO protease expression when compared to the FLUC-injected control (Fig. 7A and C), and surprisingly, a significant reduction in chymotrypsin-like activity in midgut tissue extracts at 6 h, 24 h, and 36 h PBF (Fig. 7D).
RNAi ecdysone receptor (EcR) knockdown effects on AaCHYMO protease expression and activity. (A) Western blot analysis of the EcR knockdown effect on AaCHYMO protein expression using an anti-AaCHYMO primary antibody. Midgut protein extracts were prepared from individual mosquitoes microinjected with dsRNA (RNAi-FLUC and -AaCHYMO). Each lane represents the set number of mosquito samples used for analysis. Each lane contains 0.5 midgut tissue equivalent. The Western blot is representative of 3 independent biological replicates. α-tubulin was used as an internal control. The WB was cropped for clarity. (B) The AaCHYMO bands detected by western blot (A) were quantified and normalized to α-tubulin using NIH Image J software. Data represents the mean ± SEM. **** p < 0.0001 determined using the unpaired Student’s t-test when compared to dsRNA-FLUC controls. (C) Quantification of AaCHYMO mRNA levels in EcR knockdown mosquito tissue extracts compared to the FLUC control. The experiment was conducted from 3 biological cohorts using 12 mosquitoes. Data are presented as mean ± SEM. Statistical significance is represented by stars above each comparison (unpaired Student’s t-test; **** p < 0.0001 compared to the RNAi-FLUC control samples). (D) Chymotrypsin-like activity comparison between RNAi EcR and the FLUC control midgut extract samples using the MeO-Suc-Arg-Pro-Tyr-AMC substrate. Significant reduction (****p < 0.0001) in overall activity is observed in the EcR knockdown samples (3 to 4 biological cohorts using 3 mosquitoes were tested). Please note that the original blot in (A) is presented in Supplementary File 1.
Discussion
The most studied endopeptidases and major contributors in blood meal protein digestion in the Ae. aegypti mosquito midgut are trypsin-like enzymes, with Arg and Lys amino acid preferences at the P1 site1,3,4,5,24. Other endopeptidases found in the midgut are serine collagenase-like2,3,4 and chymotrypsin-like enzymes6,7,8, but their overall contribution to blood protein digestion is still relatively unknown. Here, we aimed to understand the complex nature of proteolytic blood protein degradation by biochemically studying AaCHYMO in vitro and in vivo, the first chymotrypsin-like enzyme identified in 1997 6. This is the first step in validating if all or a select few midgut proteolytic enzymes could serve as potential inhibitor targets for the development of a new vector control strategy.
With the success of solubly expressing, activating, and purifying AaCHYMO, activity was tested using several commercially available chymotrypsin substrates. Obvious specificity differences were observed between all three (including human and bovine) chymotrypsin-like enzymes. The most preferred amino acids at the P1 position for human and bovine chymotrypsin are Phe, Trp, and Tyr, with lower preference for Leu and Met25,26. Similarly, AaCHYMO readily cleaved substrates with Phe, Tyr, Trp, Leu, and Met at P1, and only human chymotrypsin cleaved Arg and Lys substrates. This is not surprising given that the protease has been shown to cleave peptide substrates with an Arg or Lys at P1 but with an overall lower rate than when aromatic amino acids are found at this position27. Additionally, depending on which amino acids are present at P2-P4, the specificity and activity towards the preferred amino acids at P1 can be influenced27,28. For example, in bovine chymotrypsin, when comparing Suc-Ala-Ala-Pro-Phe-AMC with Suc-Ala-Ala-Phe-AMC, the specificity constant (kcat/Km) is nearly 21-fold higher when Pro is added at P2. Similar results for human chymotrypsin have been observed27,28. As for AaCHYMO, the preferred order of amino acids at P1 was determined to be Tyr, Leu, Phe, and Met using MSP-MS3, which match the in vitro activity assays using commercially available chymotrypsin substrates in this study.
Moreover, like human and bovine chymotrypsin, certain amino acids at P2-P4 influence the activity and specificity at P1 in AaCHYMO. For instance, when comparing the specificity constants (kcat/Km) of AaCHYMO with commercially available substrates to human and bovine chymotrypsin, kcat/Km is overall lower than both mammalian chymotrypsin enzymes (see the ratio comparisons in Table 1). Thus, we synthesized AaCHYMO-specific preferences at the P2-P4 sites and one substrate with a non-preferred amino acid at P2 (Ac-Ala-His-Asp-Trp-AMC). When the AaCHYMO-specific substrates were used, in most cases, the kcat/Km ratio changed to favor AaCHYMO, with substrates having Leu and Met at P1 being processed more readily than human and bovine chymotrypsin. In addition, when comparing the kcat/Km values of the AaCHYMO-specific substrate reactions, the values were greater than those determined using the commercially available substrates. As for the non-preferred amino acid substrate at P2 (Asp in this case), AaCHYMO was not able to cleave at the P1 position even though a highly preferred Trp is found at P1. Both human and bovine chymotrypsin readily and favorably cleaved the Ac-Ala-His-Asp-Trp-AMC leading to kcat/Km greater than 3 × 106 M− 1 s− 1. These results indicate the importance of knowing the amino acid preferences beyond the P1 position (P2-P4), especially if specific protease inhibitors are to be designed to target individual midgut proteases. Lastly, by performing these in vitro activity assays, we have confirmed that AaCHYMO is indeed a chymotrypsin that cannot cleave peptides with Arg or Lys at P1.
Furthermore, we set to test the overall chymotrypsin-like activity of midgut tissue extracts from sugar- and blood-fed mosquitoes, as well as in pupae, adult male mosquitoes, female carcasses (without the midgut), and midgut tissues without the food bolus (-FB). Activity was detected in the 3 h to 48 h PBF midgut tissue extracts, which corresponds to the presence of the active form of AaCHYMO. These results corroborate the work of Jiang et al.6. , who first identified the mRNA and protein expression of AaCHYMO in blood fed mosquito extracts. AaCHYMO mRNA is only present in 24 h post-emerged female mosquitoes with the protease being translated only after ingestion of blood6. Interestingly, the Jiang et al. study did not detect the presence of AaCHYMO in sugar-fed (or unfed) mosquitoes, and in our case, AaCHYMO was clearly present in these samples, but as the inactive zymogen form, with no detectable chymotrypsin-like activity. However, chymotrypsin-like activity increased after ingestion of a blood meal, with maximal activity at the 12 h to 36 h timepoints. As for mosquito tissues tested at different life stages, very low negligible activity was observed in pupae, adult males, female carcasses (without the midgut), and the midgut without the food bolus. However, in larvae and the food bolus, higher overall activity was observed. In fact, the food bolus has higher activity than even the midgut extract tissue samples from Fig. 1D. These results are not surprising since active AaCHYMO is strictly expressed for release into the midgut after ingestion of a blood meal6. The food bolus sample is expected to show such high activity as it contains all secreted proteases released to help digest blood meal proteins, and may include activity from JHA15, AaCHYMO II, AaLT, and other midgut proteases with unknown chymotrypsin-like activity. The activity detected in the larval stages may correspond to AaCHYMO II, which was shown to be strictly found in both larval and adult stages of Ae. aegypti8. However, future studies are needed to confirm the activity of AaCHYMO II in the midgut.
Knockdown studies of AaCHYMO did not lead to an effect on fecundity, but did lead to the complete elimination of chymotrypsin-like activity in the 3 h to 24 h PBF samples, and a significant decrease in activity at 36 h PBF (p < 0.0001) and 48 h PBF (p < 0.05). It is important to note that many midgut proteases are expressed and released in the mosquito midgut at the same time as active AaCHYMO. In particular, AaLT is expressed in the late phase starting at 18 h PBF and present until 36 h PBF1. With this knowledge, we performed a double knockdown of AaLT and AaCHYMO. Surprisingly, this did not lead to a change in overall chymotrypsin-like activity, indicating that a different protease or a different set of proteases may be giving rise to the residual activity. The other possibilities are JHA15 7 and AaCHYMO II8, the two additional chymotrypsin-like enzymes expressed in the mosquito midgut. Proteolytic profiling and the study of these two proteases should shed light on their role in blood meal digestion and activity at the 36 h and 48 h PBF time points.
AaCHYMO was incubated with HSA, Hb, and IgG, and the activity compared to human and bovine chymotrypsin. To our surprise, AaCHYMO led to the release of only one cleavage product in each reaction, but even then, the fragment from each reaction was not further processed by the protease. In contrast, human and bovine chymotrypsin digested HSA, Hb, and IgG, releasing several cleavage products in each reaction. This may suggest AaCHYMO is highly selective, or it requires cooperation from other proteases to expose certain amino acids for complete blood meal protein cleavage. To understand if potential PPI would occur between AaCHYMO and the different blood proteins we predicted their interactions using different docking simulations in a consensus approach. The HDOCK predictions with the three human blood proteins revealed IgG being the only protein likely to interact with AaCHYMO, which was also supported by simulations using HADDOCK 2.4 and less so by PEPPI. Our simulations supported the enzyme cleavage observed from our digestion assays, where we identified the release of an IgG cleavage product over time (see Fig. 4C). Conversely, HADDOCK 2.4 and PEPPI both predicted that Hb was not likely to interact with AaCHYMO. Despite being likely to interact based on HDOCK predictions, Hb residues were not within feasible distances close to the catalytic serine, which interestingly, in the AaCHYMO/Hb digestion assay, a single cleavage product was observed (see Fig. 4B). Lastly, despite one product being formed after cleavage of HSA in our digestion assays, the simulations were inconclusive to the likeness of albumin to interact with AaCHYMO, having few potential interactions predicted and less likely to occur. One could argue that the confirmational changes of albumin in solution at various pH29,30 could support its interaction with AaCHYMO and subsequent cleavage to occur. Arguably, this could explain our prediction outcomes, which considers only the available crystallographic data31 for the simulations.
The lack of fecundity effects by the absence of AaCHYMO and the lack of individual blood protein digestion by the protease can be explained by the presence of other midgut proteases that may compensate and work collectively to degrade blood proteins. For instance, in nematode, trematode, and plasmodia parasitic organisms, blood protein digestion follows a protease network (or cascade) involving several proteases (for an extensive review see Rascón & McKerrow32). In Ancylostoma caninum and Plasmodium falciparum, aspartic and cysteine proteases must first make initial cuts on hemoglobin, which is then further processed by metalloproteases to fully digest the blood protein32. In Ae. aegypti, after ingestion of a blood meal, several trypsin-like proteases (AaET, AaSPII-AaSPIV), chymotrypsin-like proteases (AaCHYMO, JHA15, AaCHYMO II), serine collagenase-like protease (AaSPI, AaSPV), as well as exopeptidases (amino- and carboxypeptidases) are expressed and released in the early phase (0 h to 12 h PBF), allowing these proteases to work collectively and start digesting globular blood proteins1,2,4,8,17,33. The mosquito does not complete digestion until after the second (or late) phase (approximately 40 h PBF) where active AaCHYMO is still present, along with a new set of trypsin-like proteases (AaSPVI and AaSPVII), the constitutively expressed AaSPII-AaSPV proteases, continued expression of exopeptidases, and AaLT1,2,3,17. Without the collective activity of early and late phase midgut proteases, blood protein digestion would not be effective and efficient, and the mosquito would not have the required nutrients to fuel the gonotrophic cycle. So, it is not surprising that when AaCHYMO was knocked down, there was no overall effect on digestion or fecundity. The proteolytic network in the mosquito midgut compensated for the absence of the protease, allowing the mosquito to fully digest the blood proteins needed for nutrition. Similar results were observed with the knockdown of AaET where there was no effect on egg production1, possibly due to the activity of the of other midgut proteases compensating for the knockdown. On the other hand, knockdown of the three late phase midgut proteases (AaSPVI, AaSPVII, and AaLT) did have a direct effect on nutrient release and fecundity, reducing egg production1. Therefore, it is important to study all proteases involved to delineate which would be effective targets for the development of inhibitors.
As alluded to above, the ingestion of blood by the female mosquito leads to broad yet crucial physiological consequences34,35. As blood meals are strictly linked to mosquito development36,37 and reproduction1,38, there is tight coordination between large cohorts of genes and mosquito biology in a spatiotemporal manner. Blood meal digestion occurs in a biphasic manner, and designated midgut proteases are expressed and active to digest blood proteins. Early phase protease expression is proposed to be translationally regulated while late phase protease expression is transcriptionally regulated39. However, the exact mechanisms or the players involved are still relatively unknown. The 20-hydroxyecdysone (20-E) master regulator and its interacting partner EcR are known to be involved in fecundity and oviposition18. Expression of the nuclear receptor EcR is found to increase 1–6 h PBM and again after 24 h PBM in the fat bodies and ovaries of Ae. aegypti female mosquitoes40, which correlates with midgut protease digestion of blood proteins1. Furthermore, RNAi knockdown of midgut EcR significantly decreased mRNA transcript levels of SPI, SPVI, SPVII, and LT midgut proteases17. AaCHYMO was not included in the study, and thus, we performed RNAi knockdown on EcR to observe its effect on AaCHYMO expression and activity. The knockdown of EcR led to lower AaCHYMO protein expression and significantly reduced chymotrypsin-like activity, therefore illustrating EcR’s possible role in regulating not only AaCHYMO expression and activity, but its effect on other midgut proteases. More studies focusing on EcR are needed to delineate the true role in regulating AaCHYMO and overall midgut protease expression.
Blood protein digestion in Ae. aegypti was thought to follow a simple biphasic release of midgut proteolytic enzymes, with some proteases translated almost immediately after a blood meal in the early phase (translationally controlled), followed by transcription and translation of the next set in the second phase (transcriptionally controlled)1,2, with most of the activity coming from trypsin-like proteolytic enzymes1,2,3,4,5. However, with the discovery of other serine proteases2,7,8, the mosquito seems to have evolved a complex network of proteolytic enzymes, each having a broad range of substrate specificities and activity profiles to efficiently process blood within 40 h PBF. If one is to target midgut proteolytic enzymes as potential inhibitor targets, then it is crucial to elucidate the activity profile and role of all midgut proteases. As was shown in this study, AaCHYMO is a true chymotrypsin-like enzyme cleaving Phe, Tyr, Trp, Leu, and Met at P1, but not Arg or Lys. Furthermore, knockdown of the protease did not influence fecundity or affect blood protein digestion, even though chymotrypsin-like activity was eliminated and significantly reduced. These results indicate the importance of carefully elucidating the complex network of midgut proteases that compensate for the absence of AaCHYMO. Given that no phenotypic changes were observed with the knockdown, it is likely that the mosquito evolved a redundancy in function7 to ensure complete blood meal digestion. In addition, regulation of protease expression and activity by EcR must be fully elucidated to determine if this nuclear receptor not only affects AaCHYMO but other understudied proteases. Therefore, it is important to also characterize the activity profiles and roles of AaSPI-AaSPV2, JHA15 7, and AaCHYMO II8, their mode of regulation, and effect on fecundity.
Methods
Chemicals and fluorescent substrates
TRIS base (J.T. Baker #JT4099-6), Calcium chloride (CaCl2) (J.T. Baker # JT1332-1), Tween 20 (MilliporeSigma #80503-492), 7-amino-4-methylcoumarin (AMC) (Thermo Scientific #AAA15017MD), PageRuler Prestained Protein Ladder (Thermo Scientific #PI-26616). Supplementary Table S1 lists all commercially available chymotrypsin and the AaCHYMO-specifically designed fluorescent AMC substrates used in this study. AaCHYMO-specific substrates were synthesized by Biomatik USA, LLC (Wilmington, DE) based on the identification of preferred amino acids at the P1 to P4 sites3.
AaCHYMO enzymatic assays and kinetic parameter determination
Recombinant AaCHYMO was expressed in SHuffle T7 Express Competent Escherichia coli Cells (New England Biolabs #C3029J), purified using a 5 mL HisTRAP FF column (Cytiva #17525501) on the AKTA Pure 25 L (Cytiva, Marlborough, MA), and activated via buffer exchange, as described3. Kinetic parameters were then determined in activity assay buffer containing 20 mM TRIS-HCl pH 7.2 and 0.1% Tween 20 (30 µL total volume in a 384-well black microplate (Thermo Scientific # 262260)). Active AaCHYMO concentrations were in the range of 5 to 100 nM and incubated with varying commercially available chymotrypsin fluorescent substrate concentrations or specific-AaCHYMO designed fluorescent substrates (Table 1) (under steady-state conditions). For comparison, 50 pM to 50 nM human pancreas chymotrypsin (Athens # 16-19-030820) and bovine chymotrypsin alpha (Abnova # P5212) were tested under the same reaction conditions. Reaction rate slopes were measured in triplicate using the Tecan Spark (Männedorf, Switzerland) at 360 nm excitation and 460 nm emission wavelengths. Chymotrypsin activity was monitored by the release of 7-amino-4-methylcoumarin (AMC). A standard curve using AMC was used to convert relative fluorescence units per sec (RFU’s/sec) to a change in product concentration over time (µM/min). Briefly, AMC stocks from 0 to 100 µM (serial dilution) were prepared in activity assay buffer and the fluorescence at each concentration was measured at 360 nm/460 nm in duplicates. The values were plotted on Excel and the slope determined using a linear regression plot. To compare all chymotrypsin data, a final 5 nM enzyme concentration was used to estimate kinetic constants (vmax, kcat, and Km) using Michaelis-Menten non-linear regression analysis at a 95% Confidence Interval (CI) on GraphPad Prism version 10.4.0. Comparison assays between AaCHYMO, human and bovine chymotrypsin, were performed using substrates that were specifically designed for AaCHYMO. The lower level of AMC detection was determined by preparing a serial dilution from 1 nM to 1 pM AMC in activity assay buffer, as recommended in the Tecan Spark manual. Dilution fluorescent readings at each concentration was measured at 360 nm/460 nm in duplicates. The values were plotted on Excel and the slope determined using a linear regression plot.
Mosquito rearing, blood feeding, and tissue Preparation
Ae. aegypti mosquitoes (Rockefeller strain) were maintained on a 10% sucrose diet until feeding, with rearing conditions set at room temperature (25 °C), 80% relative humidity, and a 16 h light: 8 h dark cycle. Mosquitoes were fed whole bovine blood with citrate anticoagulant purchased from HemoStat Laboratories (cat. #BBC500, Dixon, CA). It is important to note that no animals or humans were involved in this study. The mosquitoes were artificially fed through stretched parafilm on a glass feeder. Mosquito midguts were dissected in 1x PBS under a light microscope and transferred to 20 mM TRIS-HCl pH 7.2 buffer. Three midguts per 100 µL was prepared for a final concentration of 0.03 midgut/µL. Mosquito midgut tissues were dissected at 3-, 6-, 12-, 24-, 36-, 48-, and 72-hours post-blood feeding (PBF), and as a control, sugar fed midgut extracts were used. Other samples isolated were the Ae. aegypti female carcass (without the midgut and food bolus), midgut minus the food bolus, the food bolus only, larvae, pupae, and adult male mosquitoes. These samples were also processed as the midgut extracts, 3 per 100 µL of 20 mM TRIS-HCl pH 7.2 (for a total of 4 biological cohorts). All samples were immediately flash frozen in liquid nitrogen and stored at -80 °C until needed.
Synthesis of double-stranded RNA (dsRNA)
Genes encoding Ae. aegypti AaCHYMO (EAT45655; AAEL003060), AaLT (EAT34478; AAEL013284), and EcR (EAT38529; AAEL009600) were identified from the mosquito genome in the NCBI database. The T7 promoter sequence (5’ TAATACGACTCACTATAGGGAGA 3’) was added to the 5’-end of both the forward and reverse primers for each gene (Supplementary Table S2). PCR was performed to amplify the dsRNA region of the DNA and sequences verified before use. dsRNA targeting each gene were synthesized using the NEB HiScribe T7 RNA Synthesis kit (New England Biolabs #E2040S) with PCR amplified DNA templates. Purified dsRNA was then resuspended in nuclease-free HPLC water at 7.5 µg/µL and stored in the − 80 °C freezer until use. Ae. aegypti females were microinjected with 2.0 µg of dsRNA using a Nanoject II micro-injector (Drummond Scientific Company, Broomall). The injection was performed within 4 h after adult eclosion, and the dsRNA microinjected mosquitoes were maintained on 10% sucrose until needed for experiments. AaCHYMO, LT, a combination of AaCHYMO/LT, and EcR dsRNA microinjections were performed. The firefly luciferase dsRNA microinjection was used as a negative control.
Processing of mosquito tissues and Chymotrypsin-like activity determination
All isolated wildtype (WT) and dsRNA injected mosquito tissues were processed via sonication utilizing the Sonic Dismembrator (Fisherbrand Model 120) with a 5/64-inch microtip. Samples were thawed on ice, followed by quick vortex mixing (10 s) and centrifugation (using the mini-table top centrifuge for 10 s), then samples lysed using the dismembrator (25% amplitude (AMP)) for 10 s (3x total). To avoid overheating, samples were set on ice for about 30 s, while the other samples were being processed. The microtip was cleaned with ultrapure water and wiped dry with a Kimwipe tissue each time before the next sample was processed to avoid cross-contamination. For the female carcass and the adult males, samples were sonicated 5 times to ensure proper lysis. After lysing, all samples were then centrifuged at full speed in the VWR MicroStar 21 temperature-controlled centrifuge (14,800 rpm, 8 °C) to remove any tissue, particles, or contaminants away from the lysate. The lysates were then transferred to a new tube and flash frozen in liquid nitrogen and stored at -80 °C until needed.
To test activity in all WT and dsRNA-injected mosquito tissue extracts, the best commercially available substrate processed by AaCHYMO (MeO-Suc-Arg-Pro-Tyr-AMC) was used (see Table 1). Given that mosquito midgut extracts contain several midgut proteases that can potentially process the substrate, either a 250- or 10,000-fold dilution in activity assay buffer (20 mM TRIS-HCl pH 7.2 and 0.1% Tween 20) was prepared to test for activity (30 µL reactions, similar setup as above for the recombinant AaCHYMO kinetic parameter assays). However, the final substrate concentration used was 25 µM to ensure linear regression activity during the run. A minimum of 3–6 replicates were performed for nearly all tissue extracts. Data was statistically analyzed by unpaired Student’s t-test with mean values ± SEM using GraphPad Prism version 10.4.0. Asterisks indicate significant differences (**p < 0.05; ****p < 0.0001; ns, not significant). To determine significant differences between groups, the one-way ANOVA with Tukey multiple comparisons was employed.
Western blot analysis of mosquito midgut tissue extracts
A polyclonal antibody against AaCHYMO was prepared by GenScript (Piscataway, NJ) using the antigenic AaCHYMO protein sequence without the signal/leader peptide. Western blotting was performed as previously described for other mosquito proteins41,42. Briefly, midgut protein extracts (midgut epithelial cells without the food bolus) were separated via 12% SDS-PAGE gels, electroblotted onto nitrocellulose membranes (LI-COR Biosciences), incubated with AaCHYMO and α-tubulin antibodies at 4oC overnight. The membranes were washed with 1x PBST and incubated with the secondary antibodies for 1 h at room temperature. Visual detection was performed with the Odyssey XF Infrared Imaging System (LI-COR Biosciences). The dilutions of the primary antibodies were as follows: AaCHYMO antibody (1:1000) and α-tubulin antibody (1:3000). The secondary antibodies (LiCor IRDye 800CW goat anti-rabbit and LiCor IRDye 680RD donkey anti-mouse) were diluted at 1:10000. ImageJ software was used to quantify protein band intensity. Each band intensity was normalized to α-tubulin band signals. Experiments were conducted from 3 biological cohorts using 5 to 10 mosquitoes. For AaCHYMO time course studies, the protein levels were analyzed by ANOVA with Tukey’s post-hoc test. Unpaired Student’s t-test using GraphPad Prism was used to determine whether there is a statistical difference between the two RNAi groups.
A chemiluminescent WB analysis of midgut extracts (midgut epithelial cells with the food bolus), which are the representative samples used for the detection of chymotrypsin-like activity, was also done. Midgut samples were sonicated and prepared as describe above. For this WB, 0.5 midgut equivalents were used, separated using a 4–12% BIS-TRIS gel (12-well, Invitrogen # NP0322BOX), electroblotted to a PVDF membrane (Millipore Sigma Immobilon-PSQ #ISEQ00010), incubated with a 1:1500 dilution of AaCHYMO primary antibody at 4oC overnight. The membrane was washed with 1x TBST and incubated with a 1:2000 dilution of the secondary antibody (Amersham ECL Anti-Rabbit IgG #NA934-1ML) for 1 h at room temperature. Visual detection was performed with the chemiluminescent setting on the BioRad ChemiDoc MP Imaging System (Hercules, CA) after incubating the membrane with the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific #PI34577) for 30 s.
Validating RNAi knockdown efficiency
Single mosquito analysis was used to verify knockdown efficiency from dsRNA-microinjected mosquitoes. Midgut tissue samples were dissected after blood feeding. Proteins were extracted in 1x lysis buffer, while total RNAs were isolated with TRIzol (Invitrogen). Optical densities of total RNAs were determined using the Nanodrop (Thermo Scientific). DNaseI-treated total RNAs (200 ng) were used to synthesize complementary DNA (cDNA) using an oligo-(dT)-VN primer and reverse transcriptase (Promega). Quantitative real-time PCR (qPCR) was performed with Maxima SYBR Green qPCR Master Mix (Thermo Scientific) and gene-specific primers (final concentration at 200 nM, Supplementary Table S2) using the CFX Connect qPCR instrument (BioRad). Knockdown efficiency was compared using FLUC dsRNA-microinjected female control mosquitoes. Relative mRNA expression for AaCHYMO, EcR, and LT were normalized to ribosomal protein S7 mRNA levels in the same cDNA samples. Data was obtained from individual midgut of 12 mosquitoes. Data are presented as mean ± SEM. Statistical significance is represented by stars above each comparison (unpaired Student’s t-test; **** p < 0.0001 compared to the RNAi-FLUC control samples).
Assessing protein-protein interactions (PPI) using a molecular Docking consensus
The AaCHYMO midgut sequence (FASTA) was submitted to AlphaFold2 43 via ColabFold44 (v1.5.5; https://github.com/sokrypton/ColabFold) for modeling of its three-dimensional (3D) structure. The model, herein termed AaCHYMO, was predicted with options set as default, and structures were not relaxed using amber. Molecular docking was performed with three different software in a consensus approach for potential protein-protein interactions (PPI), assessing three proteins suggested as substrates: human serum albumin (PDB ID: 1E7H45), human hemoglobin (PDB ID: 1GZX46), and human neutralizing IgG (PDB ID: 1HZH47). First, HDOCK48, which employs a combination of template-based modeling and free docking, was used by submitting each pair of .pdb files (http://hdock.phys.hust.edu.cn/). Next, the pipeline for the extraction of predicted protein-protein interactions (PEPPI23), which predicts the likelihood of sequence interactions, was employed by submitting each pair of FASTA sequences (https://zhanggroup.org/PEPPI/). Lastly, HADDOCK 2.4, which encodes information from predicted protein interfaces, was used with default parameters, while residue interaction restraints and patches were defined as random (https://rascar.science.uu.nl/haddock2.4/). The representative poses from HDOCK were selected based on docking scores and by visual inspection49 of residues within feasible distances for potential PPI (~ 5 Å)19,20. The PyMOL software (v2.5.7) was used to analyze the results and generate images.
Human blood protein digestion assays
AaCHYMO was incubated with human serum albumin (HSA) (Abcam #AB205808), hemoglobin (Hb) (MP Biomedicals, LLC. #55914), and immunoglobulin G (IgG) (Novus #NBP1-96779). In addition, for protein digestion comparison, human and bovine chymotrypsin were also incubated with the blood proteins. For these assays, a 10:1 (blood protein to protease) mass ratio was used. Reactions (50 µL) were carried out in 20 mM TRIS-HCl pH 7.2 and 10 mM CaCl2 at room temperature (25 °C). To ensure that all activity assays were the same, prepared stocks that contained each blood protein, ultrapure water, and buffers (all added together, vortexed and centrifuged), then aliquoted into 1.6 mL microcentrifuge tubes at a volume of 46 µL (so that the final mass of the blood protein was 40 µg), followed by the addition of 4 µL of 1 µg/µL protease (4 µg of protease) to initiate digestion. All reactions were vortexed, centrifuged, and left at room temperature, withdrawing samples (6.1 µL to visualize 5 µg of total protein on a gel) at 10, 20, 40, and 60 min after the addition of the protease. A no-enzyme control (6.1 µL) was also withdrawn from the main stock of blood proteins without the proteases. All samples were treated with 3.4 µL of 6x SDS dye (sample buffer) and 13.9 µL ultrapure water and stored at -20 °C until all samples were collected. Once collected, samples were thawed, vortexed, centrifuged, and incubated in a 95 °C dry bath for 4 min. Samples were loaded onto 4–12% BIS-TRIS gels (Invitrogen #NP0322BOX) and ran at 175 volts for 40 min in the presence of 1x MES (Invitrogen #NP0002-02). The gel was then stained with Simply Blue Safe Stain (Invitrogen #LC6065) and destained with ultrapure water before photo documenting using the BioRad ChemiDoc MP Imaging System (Hercules, CA).
Midgut protein extract content gel analysis
With the stocks of FLUC and RNAi AaCHYMO midgut extracts (0.03 midgut/µL) used for the detection of chymotrypsin-like activity (see above), prepared 0.006 midgut equivalents for BIS-TRIS gel analysis. Samples were diluted with 20 mM TRIS-HCl pH 7.2 to a working stock concentration of 1.2 × 10− 3 midgut/µL. From this diluted stock, 5 µL was removed and treated with 15 µl of ultrapure water and 3.4 µL of 6x SDS dye (sample buffer). Only the PBF samples were prepared for these experiments (3 h to 72 h PBF). Once all samples were prepared, they were vortexed, centrifuged, and incubated in a 95 °C dry bath for 4 min. Samples were loaded onto 4–12% BIS-TRIS gels (Invitrogen #NP0321BOX) and ran at 175 volts for 40 min in the presence of 1x MES (Invitrogen #NP0002-02). The gel was then stained with Simply Blue Safe Stain (Invitrogen #LC6065) and destained with ultrapure water before photo documenting using the BioRad ChemiDoc MP Imaging System. The experiment was repeated in triplicate with different sets of mosquito tissue extracts. For quantification and statistical analysis, the most prominent protein band species were analyzed via ImageJ, and the pixel area of each determined. The pixel area was then plotted (in triplicate) and statistically analyzed by unpaired Student’s t-test with mean values ± SEM using GraphPad Prism version 10.4.0. Asterisks indicate significant differences (*p < 0.05; ns, not significant).
Ecdysone nuclear receptor (EcR) knockdown, AaCHYMO protease expression, and activity determination
A gene encoding EcR was knocked down by the RNAi approaches described above, followed by processing of FLUC and EcR dsRNA injected mosquito tissues via sonication. Briefly, samples were removed from the − 80 °C freezer, thawed on ice, followed by quick vortex mixing (10 s) and centrifugation (10 s), then lysed using the dismembrator set at 25% amplitude (AMP) for 10 s (3x total). To avoid overheating, samples were set on ice for about 30 s, and the microtip was cleaned with ultrapure water and wiped dry with a Kimwipe to avoid cross-contamination. This was repeated for all samples. After lysing, all samples were then centrifuged at full speed in the VWR MicroStar 21 temperature-controlled centrifuge (14,800 rpm, 8 °C) to pellet the midgut tissue away from the lysate. The lysates were then transferred to a new tube and immediately flash frozen in liquid nitrogen and stored at -80 °C after use. To test activity, the MeO-Suc-Arg-Pro-Tyr-AMC commercially available substrate was used. A 10,000-fold dilution in activity assay buffer (20 mM TRIS-HCl pH 7.2 and 0.1% Tween 20) was prepared to test for activity (30 µL reactions). The final substrate concentration used was 25 µM to ensure linear regression activity during the run. A minimum of 3–6 replicates were performed for nearly all tissue extracts. Data was statistically analyzed by unpaired Student’s t-test with mean values ± SEM using GraphPad Prism. Asterisks indicate significant differences (**p < 0.05; ****p < 0.0001; ns, not significant).
Fecundity measurements of RNAi AaCHYMO mosquitoes
The knockdown effect against AaCHYMO on fecundity was examined during the first gonotrophic cycle, as previously performed50. Briefly, dsRNA-microinjected females were allowed to feed on bovine blood. Only fully engorged mosquitoes were chosen and allowed to lay eggs. Mosquitoes were individually transferred to a 15 mL vial containing wet oviposition paper at 48 h after blood feeding and allowed to lay eggs for three days. Mosquitoes that were microinjected with dsRNA against FLUC were used as controls. Eggs were counted under a light microscope. Each dot represents the number of eggs deposited by individual RNAi-mosquitoes. Experiments were conducted from 3 biological cohorts using 20 mosquitoes (total of 60 mosquitoes). Unpaired Students t-test was used to determine whether a statistical difference in fecundity between RNAi-FLUC control group and RNAi-AaCHYMO is observed.
Data availability
All data generated or analyzed during this study are included in this published article (and its Supplementary Information files) but may be made available from the corresponding author on reasonable request.
References
Isoe, J., Rascon, A. A. Jr., Kunz, S. & Miesfeld, R. L. Molecular genetic analysis of midgut Serine proteases in Aedes aegypti mosquitoes. Insect Biochem. Mol. Biol. 39, 903–912. https://doi.org/10.1016/j.ibmb.2009.10.008 (2009).
Brackney, D. E. et al. Expression profiling and comparative analyses of seven midgut Serine proteases from the yellow fever mosquito, Aedes aegypti. J. Insect Physiol. 56, 736–744. https://doi.org/10.1016/j.jinsphys.2010.01.003 (2010).
O’Donoghue, A. J. et al. Jr. Comprehensive proteolytic profiling of Aedes aegypti mosquito midgut extracts: unraveling the blood meal protein digestion system. PLoS Negl. Trop. Dis. 19(2): e0012555, https://doi.org/10.1371/journal.pntd.0012555
Rascon, A. A. Jr., Gearin, J., Isoe, J. & Miesfeld, R. L. In vitro activation and enzyme kinetic analysis of Recombinant midgut Serine proteases from the dengue vector mosquito Aedes aegypti. BMC Biochem. 12, 43. https://doi.org/10.1186/1471-2091-12-43 (2011).
Nguyen, J. T. et al. Soluble expression of Recombinant midgut Zymogen (native propeptide) proteases from the Aedes aegypti mosquito utilizing E. coli as a host. BMC Biochem. 19 https://doi.org/10.1186/s12858-018-0101-0 (2018).
Jiang, Q., Hall, M., Noriega, F. G. & Wells, M. cDNA cloning and pattern of expression of an adult, female-specific chymotrypsin from Aedes aegypti midgut. Insect Biochem. Mol. Biol. 27, 283–289. https://doi.org/10.1016/s0965-1748(97)00001-5 (1997).
Bian, G., Raikhel, A. S. & Zhu, J. Characterization of a juvenile hormone-regulated chymotrypsin-like Serine protease gene in Aedes aegypti mosquito. Insect Biochem. Mol. Biol. 38, 190–200. https://doi.org/10.1016/j.ibmb.2007.10.008 (2008).
Borovsky, D. & Rouge, P. Cloning and characterization of Aedes aegypti blood downregulated chymotrypsin II. Arch. Insect Biochem. Physiol. 113, e22018. https://doi.org/10.1002/arch.22018 (2023).
Bisia, M. et al. Secondary vectors of Zika virus, a systematic review of laboratory vector competence studies. PLoS Negl. Trop. Dis. 17, e0011591. https://doi.org/10.1371/journal.pntd.0011591 (2023).
Tajik, S. et al. Zika virus tropism and pathogenesis: Understanding clinical impacts and transmission dynamics. Virol. J. 21, 271. https://doi.org/10.1186/s12985-024-02547-z (2024).
de Souza, W. M. et al. Chikungunya: a decade of burden in the Americas. Lancet Reg. Health Am. 30, 100673. https://doi.org/10.1016/j.lana.2023.100673 (2024).
Martin, E. et al. Surveillance of Aedes aegypti indoors and outdoors using autocidal gravid ovitraps in South Texas during local transmission of Zika virus, 2016 to 2018. Acta Trop. 192, 129–137. https://doi.org/10.1016/j.actatropica.2019.02.006 (2019).
Conway, M. J., Haslitt, D. P. & Swarts, B. M. Targeting Aedes aegypti metabolism with Next-Generation insecticides. Viruses 15 https://doi.org/10.3390/v15020469 (2023).
Wang, Y. et al. Insecticide resistance: status and potential mechanisms in Aedes aegypti. Pestic Biochem. Physiol. 195, 105577. https://doi.org/10.1016/j.pestbp.2023.105577 (2023).
Tussey, D. A. et al. Developing methods for chilling, compacting, and sterilizing adult Aedes aegypti (Diptera: Culicidae) and comparing mating competitiveness between males sterilized as adults versus pupae for sterile male release. J. Med. Entomol. 60, 1038–1047. https://doi.org/10.1093/jme/tjad079 (2023).
Pinto, S. B. et al. Effectiveness of Wolbachia-infected mosquito deployments in reducing the incidence of dengue and other Aedes-borne diseases in Niteroi, Brazil: A quasi-experimental study. PLoS Negl. Trop. Dis. 15, e0009556. https://doi.org/10.1371/journal.pntd.0009556 (2021).
He, Y. Z., Ding, Y., Wang, X., Zou, Z. & Raikhel, A. S. E93 confers steroid hormone responsiveness of digestive enzymes to promote blood meal digestion in the midgut of the mosquito Aedes aegypti. Insect Biochem. Mol. Biol. 134, 103580. https://doi.org/10.1016/j.ibmb.2021.103580 (2021).
Ekoka, E., Maharaj, S., Nardini, L., Dahan-Moss, Y. & Koekemoer, L. L. 20-Hydroxyecdysone (20E) signaling as a promising target for the chemical control of malaria vectors. Parasit. Vectors. 14, 86. https://doi.org/10.1186/s13071-020-04558-5 (2021).
Li, N., Sun, Z. & Jiang, F. Prediction of protein-protein binding site by using core interface residue and support vector machine. BMC Bioinform. 9, 553. https://doi.org/10.1186/1471-2105-9-553 (2008).
Tam, J. Z., Palumbo, T., Miwa, J. M. & Chen, B. Y. Analysis of Protein-Protein interactions for intermolecular bond prediction. Molecules 27 https://doi.org/10.3390/molecules27196178 (2022).
Li, H., Huang, E., Zhang, Y., Huang, S. Y. & Xiao, Y. HDOCK update for modeling protein-RNA/DNA complex structures. Protein Sci. 31, e4441. https://doi.org/10.1002/pro.4441 (2022).
Honorato, R. V. et al. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat. Protoc. 19, 3219–3241. https://doi.org/10.1038/s41596-024-01011-0 (2024).
Bell, E. W., Schwartz, J. H., Freddolino, P. L. & Zhang, Y. P. E. P. P. I. Whole-proteome Protein-protein interaction prediction through structure and sequence similarity, functional association, and machine learning. J. Mol. Biol. 434, 167530. https://doi.org/10.1016/j.jmb.2022.167530 (2022).
Brackney, D. E., Foy, B. D. & Olson, K. E. The effects of midgut Serine proteases on dengue virus type 2 infectivity of Aedes aegypti. Am. J. Trop. Med. Hyg. 79, 267–274 (2008).
Reseland, J. E. et al. A novel human chymotrypsin-like digestive enzyme. J. Biol. Chem. 272, 8099–8104. https://doi.org/10.1074/jbc.272.12.8099 (1997).
Ma, W., Tang, C. & Lai, L. Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant. Biophys. J. 89, 1183–1193. https://doi.org/10.1529/biophysj.104.057158 (2005).
Vreeke, G. J. C., Vincken, J. P. & Wierenga, P. A. The path of proteolysis by bovine chymotrypsin. Food Res. Int. 165, 112485. https://doi.org/10.1016/j.foodres.2023.112485 (2023).
Nemeth, B. Z. et al. Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors. Pancreatology 23, 742–749. https://doi.org/10.1016/j.pan.2023.08.004 (2023).
Otosu, T., Nishimoto, E. & Yamashita, S. Multiple conformational state of human serum albumin around single Tryptophan residue at various pH revealed by time-resolved fluorescence spectroscopy. J. Biochem. 147, 191–200. https://doi.org/10.1093/jb/mvp175 (2010).
Mishra, V. & Heath, R. J. Structural and biochemical features of human serum albumin essential for eukaryotic cell culture. Int. J. Mol. Sci. 22 https://doi.org/10.3390/ijms22168411 (2021).
Ferrer, M. L., Duchowicz, R., Carrasco, B., de la Torre, J. G. & Acuna, A. U. The conformation of serum albumin in solution: a combined phosphorescence depolarization-hydrodynamic modeling study. Biophys. J. 80, 2422–2430. https://doi.org/10.1016/S0006-3495(01)76211-X (2001).
Rascon, A. A. Jr. & McKerrow, J. H. Synthetic and natural protease inhibitors provide insights into parasite development, virulence and pathogenesis. Curr. Med. Chem. 20, 3078–3102. https://doi.org/10.2174/0929867311320250005 (2013).
Isoe, J., Zamora, J. & Miesfeld, R. L. Molecular analysis of the Aedes aegypti carboxypeptidase gene family. Insect Biochem. Mol. Biol. 39, 68–73. https://doi.org/10.1016/j.ibmb.2008.09.006 (2009).
Nishiura, J. T., Ray, K. & Murray, J. Expression of nuclear receptor-transcription factor genes during Aedes aegypti midgut metamorphosis and the effect of methoprene on expression. Insect Biochem. Mol. Biol. 35, 561–573. https://doi.org/10.1016/j.ibmb.2005.01.019 (2005).
Yamanaka, N., Rewitz, K. F. & O’Connor, M. B. Ecdysone control of developmental transitions: lessons from Drosophila research. Annu. Rev. Entomol. 58, 497–516. https://doi.org/10.1146/annurev-ento-120811-153608 (2013).
Cui, Y. & Franz, A. W. E. Heterogeneity of midgut cells and their differential responses to blood meal ingestion by the mosquito, Aedes aegypti. Insect Biochem. Mol. Biol. 127, 103496. https://doi.org/10.1016/j.ibmb.2020.103496 (2020).
Taracena-Agarwal, M. L. et al. Juvenile hormone as a contributing factor in Establishing midgut microbiota for fecundity and fitness enhancement in adult female Aedes aegypti. Commun. Biol. 7, 687. https://doi.org/10.1038/s42003-024-06334-y (2024).
Roy, S. et al. Regulation of gene expression patterns in mosquito reproduction. PLoS Genet. 11, e1005450. https://doi.org/10.1371/journal.pgen.1005450 (2015).
Brandon, M. C. et al. TOR signaling is required for amino acid stimulation of early trypsin protein synthesis in the midgut of Aedes aegypti mosquitoes. Insect Biochem. Mol. Biol. 38, 916–922. https://doi.org/10.1016/j.ibmb.2008.07.003 (2008).
Wang, S. F., Miura, K., Miksicek, R. J., Segraves, W. A. & Raikhel, A. S. DNA binding and transactivation characteristics of the mosquito ecdysone receptor-Ultraspiracle complex. J. Biol. Chem. 273, 27531–27540. https://doi.org/10.1074/jbc.273.42.27531 (1998).
Isoe, J. et al. Xanthine dehydrogenase-1 Silencing in Aedes aegypti mosquitoes promotes a blood feeding-induced adulticidal activity. FASEB J. 31, 2276–2286. https://doi.org/10.1096/fj.201601185R (2017).
Isoe, J., Petchampai, N., Joseph, V. & Scaraffia, P. Y. Ornithine decarboxylase deficiency critically impairs nitrogen metabolism and survival in Aedes aegypti mosquitoes. FASEB J. 36, e22279. https://doi.org/10.1096/fj.202200008R (2022).
Jumper, J. et al. Highly accurate protein structure prediction with alphafold. Nature 596, 583–589. https://doi.org/10.1038/s41586-021-03819-2 (2021).
Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods. 19, 679–682. https://doi.org/10.1038/s41592-022-01488-1 (2022).
Bhattacharya, A. A., Grune, T. & Curry, S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303, 721–732. https://doi.org/10.1006/jmbi.2000.4158 (2000).
Paoli, M., Liddington, R., Tame, J., Wilkinson, A. & Dodson, G. Crystal structure of T state haemoglobin with oxygen bound at all four haems. J. Mol. Biol. 256, 775–792. https://doi.org/10.1006/jmbi.1996.0124 (1996).
Saphire, E. O. et al. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293, 1155–1159. https://doi.org/10.1126/science.1061692 (2001).
Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S. Y. HDOCK: a web server for protein-protein and protein-DNA/RNA Docking based on a hybrid strategy. Nucleic Acids Res. 45, W365–W373. https://doi.org/10.1093/nar/gkx407 (2017).
Fischer, A., Smiesko, M., Sellner, M. & Lill, M. A. Decision making in Structure-Based drug discovery: visual inspection of Docking results. J. Med. Chem. 64, 2489–2500. https://doi.org/10.1021/acs.jmedchem.0c02227 (2021).
Isoe, J. et al. Characterization of essential eggshell proteins from Aedes aegypti mosquitoes. BMC Biol. 21, 214. https://doi.org/10.1186/s12915-023-01721-z (2023).
Acknowledgements
Research reported in this publication was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award Number SC3GM116681 to AAR while at San José State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition, research reported in this publication was also supported by discretionary funds provided by the School of Molecular Sciences at ASU.
Author information
Authors and Affiliations
Contributions
Abigail G. Ramirez: Conceptualization, Investigation, Formal AnalysisJun Isoe: Conceptualization, Methodology, Validation, Formal Analysis, Investigation, Resources, Data Curation, Writing - Review & Editing, VisualizationMateus Sá M. Serafim: Conceptualization, Methodology, Validation, Formal Analysis, Investigation, Data Curation, Writing - Review & Editing, VisualizationDaniel Fong: Investigation, Formal AnalysisMy Anh Le: Investigation, Formal AnalysisJames T. Nguyen: Formal Analysis, Writing - Review & Editing, VisualizationOlive E. Burata: InvestigationRachael M. Lucero: InvestigationRebecca K. Spangler: InvestigationAlberto A. Rascón, Jr.: Conceptualization, Methodology, Validation, Formal Analysis, Investigation, Resources, Data Curation, Writing - Original Draft, Writing - Review & Editing, Visualization, Supervision, Project Administration, Funding Acquisition.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Ramirez, A.G., Isoe, J., Serafim, M.S.M. et al. Biochemical and physiological characterization of Aedes aegypti midgut chymotrypsin. Sci Rep 15, 9685 (2025). https://doi.org/10.1038/s41598-025-93413-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-025-93413-7